2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Rossi P et al. | Percutaneous transluminal angioplasty increases thromboxane A2 production in claudicants. | 1997 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:9175173 |
Mizugaki M et al. | Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method. | 1999 | Prostaglandins Other Lipid Mediat. | pmid:10593167 |
Hishinuma T et al. | Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabetic. | 1999 | Prostaglandins Other Lipid Mediat. | pmid:10593168 |
Hoch B and Bernhard M | Reduced prostacyclin to thromboxane A2 ratio is correlated with central apneas in preterm infants. | 1999 | Prostaglandins Other Lipid Mediat. | pmid:10593170 |
Blatnik M and Steenwyk RC | Quantification of urinary PGEm, 6-keto PGF(1alpha) and 2,3-dinor-6-keto PGF(1alpha) by UFLC-MS/MS before and after exercise. | 2010 | Prostaglandins Other Lipid Mediat. | pmid:20416393 |
Lynch CM et al. | The role of thromboxane A(2) in the pathogenesis of intrauterine growth restriction associated with maternal smoking in pregnancy. | 2011 | Prostaglandins Other Lipid Mediat. | pmid:21723954 |
Rosenkranz B et al. | Urinary and systemic metabolites of prostacyclin in the perfused rabbit kidney. | 1982 | Ren Physiol | pmid:6750728 |
Vesterqvist O et al. | Synthetic arterial grafts cause prolonged increase in the in vivo formation of thromboxane and prostacyclin in humans. | 1987 | Res Exp Med (Berl) | pmid:3303204 |
Tanaka H et al. | Can urinary eicosanoids be a potential predictive marker of clinical response to thromboxane A2 receptor antagonist in asthmatic patients? | 1999 | Respir Med | pmid:10653051 |
Vesterqvist O et al. | In vivo production of thromboxane and prostacyclin in patients following total hip arthroplasty. | 1988 | Scand. J. Clin. Lab. Invest. | pmid:3375779 |